Tags

Type your tag names separated by a space and hit enter

PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
Res Social Adm Pharm 2010; 6(2):130-42RS

Abstract

BACKGROUND

The Medicare Prescription Drug Improvement and Modernization Act of 2003 provides outpatient prescription drug coverage for Medicare beneficiaries through private insurers. This coverage is available through 2 primary venues: stand-alone prescription drug plans (PDPs) and integrated managed care (or Medicare Advantage) plans that also provide prescription drug coverage (MA-PDs).

OBJECTIVES

The first objective was to describe factors associated with Medicare beneficiaries choosing to enroll in any Medicare part D PDP. The second objective was to describe factors associated with the choice of an MA-PD, given enrollment in the part D program.

METHODS

The study used a cross-sectional, survey design. Data were collected from a stratified random sample of 5000 community-dwelling adults, aged 65 years and older in the Center for Medicaid and Medicare Services Region 25. Data were collected by means of a mailed questionnaire. Data analyses included univariate and bivariate descriptive statistics and multivariate probit modeling.

RESULTS

The overall adjusted response rate was 50.2% (2309 of 4603). Data from 1490 respondents (32.4% of those attempted) were analyzed in this study. Nearly 75% of sample members elected to enroll in one of the Medicare part D coverage options in 2007, with more than 3 times as many choosing a PDP compared with a MA-PD option (57.2% vs 17.8%). A variety of variables including rurality, plan price, perceived future need for medications, and preferences emerged as important predictors of choosing to enroll in any Medicare part D drug plan, whereas rurality, state of residence, and number of diagnosed medical conditions were associated with the decision to enroll in a MA-PD.

CONCLUSIONS

Models of health insurance demand and plan choice applied in this context appear to be modestly effective. Rurality and state of residence were particularly important contributors to both of these decisions, as were a variety of individual characteristics.

Authors+Show Affiliations

Department of Pharmaceutical Care & Health Systems, College of Pharmacy, University of Minnesota, 308 Harvard St. SE, Minneapolis, MN 55455, USA. cline011@umn.eduNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

20511112

Citation

Cline, Richard R., et al. "PDP or MA-PD? Medicare Part D Enrollment Decisions in CMS Region 25." Research in Social & Administrative Pharmacy : RSAP, vol. 6, no. 2, 2010, pp. 130-42.
Cline RR, Worley MM, Schondelmeyer SW, et al. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25. Res Social Adm Pharm. 2010;6(2):130-42.
Cline, R. R., Worley, M. M., Schondelmeyer, S. W., Schommer, J. C., Larson, T. A., Uden, D. L., & Hadsall, R. S. (2010). PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25. Research in Social & Administrative Pharmacy : RSAP, 6(2), pp. 130-42. doi:10.1016/j.sapharm.2010.04.002.
Cline RR, et al. PDP or MA-PD? Medicare Part D Enrollment Decisions in CMS Region 25. Res Social Adm Pharm. 2010;6(2):130-42. PubMed PMID: 20511112.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25. AU - Cline,Richard R, AU - Worley,Marcia M, AU - Schondelmeyer,Stephen W, AU - Schommer,Jon C, AU - Larson,Tom A, AU - Uden,Donald L, AU - Hadsall,Ronald S, PY - 2009/12/17/received PY - 2010/04/05/revised PY - 2010/04/07/accepted PY - 2010/6/1/entrez PY - 2010/6/1/pubmed PY - 2010/9/4/medline SP - 130 EP - 42 JF - Research in social & administrative pharmacy : RSAP JO - Res Social Adm Pharm VL - 6 IS - 2 N2 - BACKGROUND: The Medicare Prescription Drug Improvement and Modernization Act of 2003 provides outpatient prescription drug coverage for Medicare beneficiaries through private insurers. This coverage is available through 2 primary venues: stand-alone prescription drug plans (PDPs) and integrated managed care (or Medicare Advantage) plans that also provide prescription drug coverage (MA-PDs). OBJECTIVES: The first objective was to describe factors associated with Medicare beneficiaries choosing to enroll in any Medicare part D PDP. The second objective was to describe factors associated with the choice of an MA-PD, given enrollment in the part D program. METHODS: The study used a cross-sectional, survey design. Data were collected from a stratified random sample of 5000 community-dwelling adults, aged 65 years and older in the Center for Medicaid and Medicare Services Region 25. Data were collected by means of a mailed questionnaire. Data analyses included univariate and bivariate descriptive statistics and multivariate probit modeling. RESULTS: The overall adjusted response rate was 50.2% (2309 of 4603). Data from 1490 respondents (32.4% of those attempted) were analyzed in this study. Nearly 75% of sample members elected to enroll in one of the Medicare part D coverage options in 2007, with more than 3 times as many choosing a PDP compared with a MA-PD option (57.2% vs 17.8%). A variety of variables including rurality, plan price, perceived future need for medications, and preferences emerged as important predictors of choosing to enroll in any Medicare part D drug plan, whereas rurality, state of residence, and number of diagnosed medical conditions were associated with the decision to enroll in a MA-PD. CONCLUSIONS: Models of health insurance demand and plan choice applied in this context appear to be modestly effective. Rurality and state of residence were particularly important contributors to both of these decisions, as were a variety of individual characteristics. SN - 1934-8150 UR - https://www.unboundmedicine.com/medline/citation/20511112/PDP_or_MA_PD_Medicare_part_D_enrollment_decisions_in_CMS_Region_25_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1551-7411(10)00044-6 DB - PRIME DP - Unbound Medicine ER -